Calcitriol - Abbott

Drug Profile

Calcitriol - Abbott

Alternative Names: Calcijex; Dihydroxycholecalciferol - Abbott; Dihydroxyvitamin D3 - Abbott

Latest Information Update: 16 Jul 1999

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
  • Mechanism of Action Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hyperparathyroidism; Hypocalcaemia; Hypoparathyroidism; Osteodystrophy

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 16 Jul 1999 A phase I trial in patients with advanced cancer has been added to the therapeutic trials, adverse events and pharmacokinetics sections
  • 16 Jul 1999 Phase-I clinical trials for Cancer in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top